Join the Webinar on Immunoglobulin Access and Stewardship in the UK and Australia – ISBT
International Society of Blood Transfusion (ISBT) posted on LinkedIn:
“ISBT Webinar: UK and Australia – Two Models for Managing Immunoglobulin Appropriateness and Access
Join us on 1 April 2026, 2–3pm CEST for an insightful session exploring how the UK and Australia govern immunoglobulin (Ig) use.
Learn how national structures, data-driven stewardship, and practical oversight strategies ensure appropriate Ig access – even during shortages.
What you’ll take away:
- How Ig governance and funding work in the UK and Australia
- Methods for patient-level Ig data collection and feedback
- Practical approaches to prescribing oversight and stewardship
- Ideas to guide policy, monitoring, and equitable access in your own country
Speakers
Siraj Misbah – Consultant Immunologist, Oxford University Hospitals
Nicolle Ginman – Nurse Consultant, Immunoglobulin Program, Royal Adelaide Hospital
Don’t miss this opportunity to gain concrete ideas for strengthening Ig policy and stewardship!”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly